Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma (Jun 2022)

CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury (Feb 2020)

Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy (Jul 2019)

Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS (Nov 2016)